{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:58:57Z","timestamp":1776283137711,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100010318","name":"University of Manitoba","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010318","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12877-016-0275-5","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T15:24:00Z","timestamp":1462980240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The safety of meperidine prescribing in older adults: A longitudinal population-based study"],"prefix":"10.1186","volume":"16","author":[{"given":"Kevin J.","family":"Friesen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Falk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn","family":"Bugden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,11]]},"reference":[{"key":"275_CR1","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1176\/ajp.144.8.1062","volume":"144","author":"SJ Eisendrath","year":"1987","unstructured":"Eisendrath SJ, Goldman B, Douglas J, Dimatteo L, Van Dyke C. Meperidine-induced delirium. Am J Psychiatry. 1987;144:1062\u20135.","journal-title":"Am J Psychiatry"},{"key":"275_CR2","unstructured":"American Pain Society. Principles of analgesic use in the treatment of acute pain and cancer pain. 4th ed. Glenview, IL: American Pain Society; 1999."},{"key":"275_CR3","first-page":"927","volume":"126","author":"H Wallot","year":"1982","unstructured":"Wallot H, Lambert J. Drug addiction among Quebec physicians. Can Med Assoc J. 1982;126:927\u201330.","journal-title":"Can Med Assoc J"},{"key":"275_CR4","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0022-3565(24)38292-8","volume":"289","author":"DJ Walker","year":"1999","unstructured":"Walker DJ, Zacny JP. Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers. J Pharmacol Exp Ther. 1999;289:1454\u201364.","journal-title":"J Pharmacol Exp Ther"},{"key":"275_CR5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4137\/SART.S12518","volume":"7","author":"B Clubb","year":"2013","unstructured":"Clubb B, Loveday W, Ballantyne S. Meperidine: A continuing problem. Subst Abus Res Treat. 2013;7:127\u20139.","journal-title":"Subst Abus Res Treat"},{"key":"275_CR6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00045391-200201000-00010","volume":"9","author":"KS Latta","year":"2002","unstructured":"Latta KS, Ginsberg B, Barkin RL. Meperidine: a critical review. Am J Ther. 2002;9:53\u201368.","journal-title":"Am J Ther"},{"key":"275_CR7","first-page":"686","volume":"26","author":"DB Gordon","year":"2000","unstructured":"Gordon DB, Jones HD, Goshman LM, Foley DK, Bland SE. A quality improvement approach to reducing use of meperidine. Jt Comm J Qual Improv. 2000;26:686\u201399.","journal-title":"Jt Comm J Qual Improv"},{"key":"275_CR8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1592\/phco.24.8.776.36066","volume":"24","author":"CF Seifert","year":"2004","unstructured":"Seifert CF, Kennedy S. Meperidine is alive and well in the new millennium: evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy. 2004;24:776\u201383.","journal-title":"Pharmacotherapy"},{"key":"275_CR9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","volume":"60","author":"CM Campanelli","year":"2012","unstructured":"Campanelli CM. American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616\u201331.","journal-title":"J Am Geriatr Soc"},{"key":"275_CR10","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1532-5415.2011.03497.x","volume":"59","author":"MS Dimitrow","year":"2011","unstructured":"Dimitrow MS, Airaksinen MSA, Kivel\u00e4 SL, Lyles A, Leikola SNS. Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: A systematic review. J Am Geriatr Soc. 2011;59:1521\u201330.","journal-title":"J Am Geriatr Soc"},{"key":"275_CR11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1060028013504904","volume":"48","author":"SD Price","year":"2014","unstructured":"Price SD, Holman CDAJ, Sanfilippo FM, Emery JD. Association between potentially inappropriate medications from the beers criteria and the risk of unplanned hospitalization in elderly patients. Ann Pharmacother. 2014;48:6\u201316.","journal-title":"Ann Pharmacother"},{"key":"275_CR12","first-page":"8","volume":"16","author":"C Koczmara","year":"2005","unstructured":"Koczmara C, Perri D, Hyland S, Rousseaux L. Meperidine (Demerol) safety issues. Dynamics. 2005;16:8\u201312.","journal-title":"Dynamics"},{"key":"275_CR13","unstructured":"ISMP Canada Safety Bulletin. Meperidine (Demerol\u00ae): Issues in Medication Safety. 2004. http:\/\/www.ismp-canada.org\/download\/safetyBulletins\/ISMPCSB2004-08.pdf . Accessed 1 Sept 2015."},{"key":"275_CR14","first-page":"1855","volume":"154","author":"E Miller","year":"1996","unstructured":"Miller E, Blatman B, Einarson TR. A survey of population-based drug databases in Canada. Can Med Assoc J. 1996;154:1855\u201363.","journal-title":"Can Med Assoc J"},{"key":"275_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.socscimed.2007.08.017","volume":"66","author":"LL Roos","year":"2008","unstructured":"Roos LL, Brownell M, Lix L, Roos NP, Walld R, Macwilliam L. From health research to social research: privacy, methods, approaches. Soc Sci Med. 2008;66:117\u201329.","journal-title":"Soc Sci Med"},{"key":"275_CR16","first-page":"139","volume":"7","author":"KJ Friesen","year":"2015","unstructured":"Friesen KJ, Bugden SC. The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram. Drug Healthc Patient Saf. 2015;7:139\u201345.","journal-title":"Drug Healthc Patient Saf"},{"key":"275_CR17","unstructured":"WHO Collaborating Center for Drug Statistics Methodology. 2015. ATC\/DDD Index. http:\/\/www.whocc.no\/atc_ddd_index\/?code=N02AB02 . Accessed 1 Sept 2015."},{"key":"275_CR18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.amjmed.2005.01.061","volume":"118","author":"AB O\u2019Connor","year":"2005","unstructured":"O\u2019Connor AB, Lang VJ, Quill TE. Eliminating analgesic meperidine use with a supported formulary restriction. Am J Med. 2005;118:885\u20139.","journal-title":"Am J Med"},{"key":"275_CR19","first-page":"1150","volume":"64","author":"LL Raymo","year":"2007","unstructured":"Raymo LL, Camejo M, Fudin J. Eradicating analgesic use of meperidine in a hospital. Am J Heal Pharm. 2007;64:1150\u20132.","journal-title":"Am J Heal Pharm"},{"key":"275_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jecm.2012.06.002","volume":"4","author":"MT Wu","year":"2012","unstructured":"Wu MT, Wu TY, Tai YT, Chen HY, Kuo LN. A pharmacist-initiated project to reduce meperidine use in surgical patients. J Exp Clin Med. 2012;4:245\u20138.","journal-title":"J Exp Clin Med"},{"key":"275_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.2259","volume":"21","author":"JE Fisher","year":"2012","unstructured":"Fisher JE, Zhang Y, Sketris I, Johnston G, Burge F. The effect of an educational intervention on meperidine use in Nova Scotia, Canada: a time series analysis. Pharmacoepidemiol Drug Saf. 2012;21:177\u201383.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"275_CR22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/pds.2190","volume":"20","author":"B Fischer","year":"2011","unstructured":"Fischer B, Jones W, Krahn M, Rehm J. Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiol Drug Saf. 2011;20:1269\u201377.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"275_CR23","first-page":"179","volume":"22","author":"K Friesen","year":"2015","unstructured":"Friesen K, Woelk C, Bugden S. Regional prescribing patterns in the assessment of the response to safety warnings for meperidine. J Popul Ther Clin Pharmacol. 2015;22(2):179\u201388.","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"275_CR24","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1345\/aph.1H018","volume":"40","author":"LM Hess","year":"2006","unstructured":"Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: A proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280\u20138.","journal-title":"Ann Pharmacother"},{"key":"275_CR25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/M13-1705","volume":"160","author":"R Tamblyn","year":"2014","unstructured":"Tamblyn R, Eguale T, Huang A, Winslade N, Doran P. The incidence and determinants of primary nonadherence with prescribed medication in primary care: A cohort study. Ann Intern Med. 2014;160:441\u201350.","journal-title":"Ann Intern Med"},{"key":"275_CR26","first-page":"167","volume":"16","author":"ML Buck","year":"2011","unstructured":"Buck ML. Is meperidine the drug that just Won\u2019t Die? J Pediatr Pharmacol Ther. 2011;16:167\u20139.","journal-title":"J Pediatr Pharmacol Ther"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-016-0275-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T03:35:31Z","timestamp":1748921731000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-016-0275-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,11]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1186\/s12877-016-0275-5","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,11]]},"article-number":"100"}}